会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Antivibration device
    • 防振装置
    • US07021613B2
    • 2006-04-04
    • US10374041
    • 2003-02-27
    • Masafumi MikamiKatsutaka Momose
    • Masafumi MikamiKatsutaka Momose
    • B60G11/22
    • B60G21/0551B60G2200/21B60G2204/1434B60G2204/41042F16F1/3814F16F1/387
    • A toe correction bushing (1) is composed of a main body (2) and a stopper member (3), wherein the main body (2) is integrally provided with an inner cylinder (4), an outer cylinder (5), and an elastic body (6). The outer cylinder (5) is provided at part of the axial end with an outwardly opening inclined section (7). A recessed space (8) is provided inside of the inclined section (7). The stopper member (3) is provided with a circular plate section (20) and a stopper projection (23) at the peripheral section thereof. A boss (21) provided at the central section of the stopper member (3) is press-fitted into one end of the inner cylinder (4) for integration and at the same time, the stopper projection (23) is caused to engage the recessed space (8). When a lateral force F to the right is applied to the outer cylinder (5), the axial movement of the outer cylinder (5) is controlled by the stopper projection (23) and displaced in the direction perpendicular to the axis by an inclined plane (24) for toe correction. It is possible to change characteristics of the toe correction by changing the material, shape or the like of the stopper projection (23).
    • 脚趾修正衬套(1)由主体(2)和止动构件(3)构成,其中主体(2)整体地设置有内筒(4),外筒(5)和 弹性体(6)。 外筒(5)在轴向端部的一部分设置有向外开口的倾斜部(7)。 凹部空间(8)设置在倾斜部(7)的内部。 止动构件(3)在其周边部分设置有圆板部分(20)和止动突起(23)。 设置在止动构件(3)的中央部的凸台(21)压配合到内筒(4)的一端以一体化,同时使止动突起(23)与 凹陷空间(8)。 当向外筒(5)施加右侧的横向力F时,通过止动突起(23)控制外筒(5)的轴向移动,并使其与垂直于轴线的方向移动一倾斜平面 (24)用于脚趾矫正。 可以通过改变止动突起(23)的材料,形状等来改变脚趾校正的特性。
    • 4. 发明申请
    • 1-Amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1,4-benzodioxane derivatives
    • 1-酰氨基-3-(2-羟基苯氧基)-2-丙醇衍生物及其制备方法2-氨基甲基-1,4-苯并二恶烷衍生物
    • US20060019993A1
    • 2006-01-26
    • US11183746
    • 2005-07-19
    • Yasushi MikiMasafumi Mikami
    • Yasushi MikiMasafumi Mikami
    • A61K31/44A61K31/40A61K31/277A61K31/325A61K31/16
    • C07D209/48C07D405/06
    • An 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivative represented by the following formula (1), wherein cycle A may have further 1 to 4 substituents, and said substituent means a substituent selected from the group consisting of saturated or unsaturated C1-4 alkyl group, aralkyl group in which alkyl moiety has 1 to 4 carbon atoms, aryl group, halogen atom, halogenated C1-4 alkyl group, C2-5 alkanoyl group, mono or dialkylcarbamoyl group in which alkyl moiety has 1 to 4 carbon atoms, cyano group and nitro group, and the substituents at positions 3 and 6, or at positions 4 and 5 on the cycle A are different each other. Other ring may be fused at positions 3 and 4, or at positions 5 and 6 on the cycle A to form a condensed polycyclic hydrocarbon with the cycle A. R1 is alkanoyl group or aroyl group, and R2 is hydrogen atom, alkanoyl group or aroyl group, or R1 and R2 may be combined together with the N atom to form a cyclic imido group, which is useful as an intermediate of medicines, etc.
    • 由下式(1)表示的1-酰胺基-3-(2-羟基苯氧基)-2-丙醇衍生物,其中环A可以具有1〜4个取代基,所述取代基是指选自饱和的 或不饱和C 1-4烷基,其中烷基部分具有1至4个碳原子的芳烷基,芳基,卤素原子,卤代C 1-4烷基,C 2-5烷酰基,其中烷基部分具有1个的单或二烷基氨基甲酰基 至4个碳原子,氰基和硝基,并且在循环A上位置3和6,或位置4和5的取代基彼此不同。 其它环可以在循环A的3和4位或5和6位融合,形成具有循环A的缩合多环烃.R 1是烷酰基或芳酰基,R O 2是氢原子,烷酰基或芳酰基,或者R 1和R 2可以与N原子一起形成环状 亚胺基,可用作药物中间体等。
    • 10. 发明授权
    • 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1,4-benzodioxane derivatives
    • 1-氨基-3-(2-羟基苯氧基)-2-丙醇衍生物及其制备方法2-氨基甲基-1,4-苯并二恶烷衍生物
    • US07368608B2
    • 2008-05-06
    • US11183746
    • 2005-07-19
    • Yasushi MikiMasafumi Mikami
    • Yasushi MikiMasafumi Mikami
    • C07C217/02C07C45/29C07D209/48C07D321/00
    • C07D209/48C07D405/06
    • An 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivative represented by the following formula (1), wherein cycle A may have further 1 to 4 substituents, and said substituent means a substituent selected from the group consisting of saturated or unsaturated C1-4 alkyl group, aralkyl group in which alkyl moiety has 1 to 4 carbon atoms, aryl group, halogen atom, halogenated C1-4 alkyl group, C2-5 alkanoyl group, mono or dialkylcarbamoyl group in which alkyl moiety has 1 to 4 carbon atoms, cyano group and nitro group, and the substituents at positions 3 and 6, or at positions 4 and 5 on the cycle A are different each other. Other ring may be fused at positions 3 and 4, or at positions 5 and 6 on the cycle A to form a condensed polycyclic hydrocarbon with the cycle A. R1 is alkanoyl group or aroyl group, and R2 is hydrogen atom, alkanoyl group or aroyl group, or R1 and R2 may be combined together with the N atom to form a cyclic imido group, which is useful as an intermediate of medicines, etc.
    • 由下式(1)表示的1-酰胺基-3-(2-羟基苯氧基)-2-丙醇衍生物,其中环A可以具有1〜4个取代基,所述取代基是指选自饱和的 或不饱和C 1-4烷基,其中烷基部分具有1至4个碳原子的芳烷基,芳基,卤素原子,卤代C 1-4烷基,C 2-5烷酰基,其中烷基部分具有1个的单或二烷基氨基甲酰基 至4个碳原子,氰基和硝基,并且在循环A上位置3和6,或位置4和5的取代基彼此不同。 其它环可以在循环A的3和4位或5和6位融合,形成具有循环A的缩合多环烃.R 1是烷酰基或芳酰基,R O 2是氢原子,烷酰基或芳酰基,或者R 1和R 2可以与N原子一起形成环状 亚胺基,可用作药物中间体等。